Skip to Content

During the funding lapse, Federalregister.gov is not being supported. If data feeds are not available from GPO, FederalRegister.gov will not be updated, so please use the official edition of the Federal Register on Govinfo (https://www.govinfo.gov/app/collection/fr). If there is a technical issue with the Public Inspection List, you can view the documents on public inspection at our office in Washington, DC or on archives.gov.

Notice

Evaluating the Therapeutic Potential of Cannabinoids: How To Conduct Research Within the Current Regulatory Framework

A Notice by the National Institutes of Health on 12/03/2018

Document Details

Information about this document as published in the Federal Register.

Printed version:
PDF
Publication Date:
12/03/2018
Agencies:
National Institutes of Health
Dates:
The meeting will be held on December 8, 2018, from 8:00 a.m. to 5:30 p.m. (EST).
Document Type:
Notice
Document Citation:
83 FR 62326
Page:
62326-62327 (2 pages)
Document Number:
2018-26127
Document Details
Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Page views:
286
as of 01/08/2019 at 4:15 pm EST
Document Statistics
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institutes of Health, HHS.

ACTION:

Notice.

SUMMARY:

This workshop on December 8, 2018, sponsored by the National Center for Complementary and Integrative Health (NCCIH), a component of the National Institutes of Health (NIH), will bring together researchers, governmental officials, and industry representatives to discuss the processes and issues related to conducting cannabinoid research.

Start Printed Page 62327

DATES:

The meeting will be held on December 8, 2018, from 8:00 a.m. to 5:30 p.m. (EST).

ADDRESSES:

The meeting will be videocast. A link to the videocast will be posted on the NCCIH website, https://nccih.nih.gov/​node/​12170, once available.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For information concerning this meeting, see the NCCIH website, https://nccih.nih.gov/​node/​12170, or contract Dr. Angela Arensdorf, Science Policy Analyst, Office of Policy, Planning, and Evaluation, National Center for Complementary and Integrative Health, 9000 Rockville Pike, Building 31, Suite 2B11, Bethesda, MD 20892, telephone: 301-827-8277; email: angela.arensdorf@nih.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

This workshop will be an all-day meeting held on December 8, 2018 and will bring together representatives from the NIH, FDA, DEA, academia, and industry to discuss the issues related to conducting research with cannabinoids. The goals of this meeting are to gain an understanding of how to navigate this regulatory space, discuss future research opportunities, and foster collaborations. The focus of this workshop will be on the state of the science and working within current regulations. This meeting will NOT discuss challenging or changing current Federal laws, policies or regulations.

Start Signature

Dated: November 23, 2018.

David Shurtleff,

Acting Director, National Center for Complementary and Integrative Health, National Institutes of Health.

End Signature End Supplemental Information

[FR Doc. 2018-26127 Filed 11-30-18; 8:45 am]

BILLING CODE 4140-01-P

Published Document